<DOC>
	<DOCNO>NCT00249977</DOCNO>
	<brief_summary>1 . To determine safety feasibility administer Capecitabine combination Cisplatin Irinotecan . 2 . To determine Phase II recommend dose toxicity profile Capecitabine combination Cisplatin Irinotecan . 3 . To study biologic effect pyrimidine inhibition DNA repair camptothecin therapy .</brief_summary>
	<brief_title>Phase I Study Capecitabine Combination With Cisplatin Irinotecan</brief_title>
	<detailed_description>RATIONALE : Many study test combination cisplatin irinotecan . Side effect well describe . The two drug synergistic . The standard care colon cancer combination 5-FU , leucovorin irinotecan ( Saltz regimen ) . Recently , oxaliplatin introduce treatment colon cancer . Combination oxaliplatin 5FU ( Folfox4 ) show comparable activity Saltz regimen . Furthermore , one author recently publish triple combination oxaliplatin , 5FU irinotecan , impressive clinical activity colon cancer . There evidence 5FU impairs DNA repair . One putative resistance mechanism topoisomerase I inhibitor increase DNA repair . We therefore hypothesize inhibition DNA repair capecitabine may increase activity combination cisplatin irinotecan . This study open patient solid tumor fail line chemotherapy</detailed_description>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>All patient , 18 year age old , incurable advanced cancer effective therapy eligible . Patients must life expectancy least 12 week . Patients must Zubrod performance status 02 . Patients must sign informed consent . Patients adequate bone marrow function define absolute peripheral granulocyte count &gt; 1,500 cells/mm3 platelet count &gt; 100,000/mm3 absence regular red blood cell transfusion requirement . Patients adequate hepatic function total bilirubin &lt; 2 mg/dl SGOT SGPT &lt; two time upper limit normal , adequate renal function define serum creatinine &lt; 1.5 x upper limit normal . Patients symptomatic brain metastasis exclude study . Pregnant woman nurse mother eligible trial . Patients child bear potential must use adequate contraception . Patients may receive concurrent chemotherapy radiation therapy trial . Patients severe medical problem uncontrolled diabetes mellitus cardiovascular disease active infection eligible trial . Patients whose cancer progress receive 5FU , cisplatin irinotecan .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Phase I</keyword>
	<keyword>solid tumor</keyword>
	<keyword>DNA repair</keyword>
</DOC>